Catalyst Wire Dossier Catalyst Wire Dossier

Vidaza (5-azacytidine)

5-azacytidine · Celgene
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Vidaza (5-azacytidine), covering 2025-04-08 to 2025-04-08. Get the full timeline:

Most recent: Clinical Trial Update: Infusion of 5-Azacytidine (5-AZA) Into the Fourth Ventricle in Patients With Recurrent Posterior Fossa Ependymoma [Phase 1]

See pricing